Skip to main content
OpenTrials

Clinical trial condition

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Explore clinical trials studying Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia trial results

Completed

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT01445080

Conditions
Blast Crisis, Blastic Phase, Bone Marrow Diseases, +33 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions
Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
  • Princess Margaret Hospital Cashmere, Canterbury, New Zealand
View Trial Details

Related conditions